Mylan news

Mylan Inc. Raises FY 2009 EPS Guidance; Comments On FY 2010 Guidance

Reuters Key Development - 1 hour ago

Mylan Laboratories swings to loss, raises outlook

MarketWatch - 1 hour ago
LONDON (MarketWatch) -- Mylan Laboratories (NASDAQ:MYL) on Thursday reported a third-quarter net loss of $40 million, or 13 cents a share, compared to profit of $182.4 million, or 47 cents a share ...

Mylan Reports Third Quarter Adjusted Diluted EPS of $0.32

MSN Money - 33 minutes ago
PITTSBURGH, Oct. 29 /PRNewswire-FirstCall/ -- Mylan Inc. MYL today announced its financial results for the three and nine months ended September 30, 2009. On a GAAP basis, earnings per diluted ...

Mylan Slips To Loss In Q3; Lifts FY09 Adj. EPS View - Quick Facts

DIARY - S&P 500 Corporate Earnings for Thursday Oct 29, 2009

Reuters - 1 hour ago
ESTIMATE EST EPS 29 Oct Q1 Harman Intl. Industries (HAR) -0.23 5 0.51 29 Oct Q1 KLA-Tencor (KLAC.O) 0.01 16 0.32 29 Oct BMO Q1 Meredith Corp. (MDP) 0.33 6 0.41 29 Oct Q1 Procter & Gamble Co. (PG ...

Mylan Inc.'s Dey Pharma, L.P. Launches EpiPen Auto-Injector 0.3/0.15 mg

Reuters Key Development - 1 hour ago

Dey Launches and Unveils Next-Generation, Needle-Protected EpiPen(R) (Epinephrine) Auto-Injector with Enhanced Patient-Friendly Features

Dey Launches and Unveils Next-Generation, Needle-Protected EpiPen(R) (Epinephrine) Auto-Injector with Enhanced Patient-Friendly Features

News for Mylan Inc. - Google Finance